Royal Bank Of Canada Biofrontera Inc. Transaction History

Royal Bank Of Canada

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.4 - $0.65 $6 - $10	-16 Reduced 7.11%	209 $0
Q1 2023 May 15, 2023	BUY	$0.56 - $1.02 $126 - $229	225 New	225 $0
Q3 2022 Nov 14, 2022	BUY	$0.82 - $41.8 $86 - $4,430	106 New	106 $0
Q1 2022 May 16, 2022	SELL	$45.0 - $138.4 $1,125 - $3,460	-25 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$49.4 - $263.4 $1,235 - $6,584	25 New	25 $0

Ticker BFRI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 23,551,000
Market Cap $27.1M
Description
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in combination with the company's licensor's medical device; and the RhodoLED lamp series for phot...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.